Timoptol is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.
For this indication, competent medicine agencies globally authorize below treatments:
Ophthalmic
2 - 2 {drops}
From 1 To 1 {drops} 2 time(s) per day every day
Recommended therapy is one drop 0.25% solution in the affected eye twice a day.
If clinical response is not adequate, dosage may be changed to one drop 0.5% solution in each affected eye twice a day. If needed, Timoptol may be used with other agent(s) for lowering intra-ocular pressure. The use of two topical beta-adrenergic blocking agents is not recommended.
Intra-ocular pressure should be reassessed approximately four weeks after starting treatment because response to Timoptol may take a few weeks to stabilise.
Provided that the intra-ocular pressure is maintained at satisfactory levels, many patients can then be placed on once-a-day therapy.